Related Experiment Videos
Nonlipoprotein risk factors for coronary heart disease: evaluation and management
1Department of Medicine, University of California Medical Center, San Francisco 94143-0124, USA.
Insights
Effective coronary heart disease (CHD) prevention integrates risk factor reduction, including lipids, blood pressure, and smoking cessation. Lifestyle changes and aspirin therapy are key for managing CHD and its risk factors.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Coronary heart disease (CHD) poses a significant global health burden.
- Effective management necessitates a comprehensive strategy targeting multiple risk factors.
Purpose of the Study:
- To outline an integrated approach for the prevention and management of coronary heart disease (CHD).
- To identify key modifiable and nonmodifiable risk factors for CHD.
Main Methods:
- Review of established guidelines and evidence for CHD risk factor reduction.
- Analysis of lifestyle interventions and pharmacological therapies.
Main Results:
- Key risk factors include elevated lipids, hypertension, and smoking.
- Lifestyle modifications such as exercise, diet, and weight management are crucial.
- Aspirin therapy is recommended for patients with established CHD and selected high-risk individuals.
Conclusions:
- An integrated approach combining risk factor reduction, lifestyle changes, and appropriate pharmacotherapy is essential for CHD prevention and management.
- Addressing both modifiable and nonmodifiable risk factors improves patient outcomes.
Abstract:
Appropriate prevention and management of coronary heart disease (CHD) requires an integrated approach to the reduction of risk factors. These principally include reduction of elevated lipids, control of blood pressure, and cessation of smoking. In addition, appropriate exercise, diet, and weight reduction (where necessary) are also important. Control of diabetes and stress management may also be helpful. Aspirin therapy is appropriate for all patients with known CHD and selected patients without CHD who have several risk factors, including nonmodifiable risk factors such as age, a positive family history, and male gender.